Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, China.
J Cosmet Dermatol. 2022 Aug;21(8):3386-3392. doi: 10.1111/jocd.15046. Epub 2022 May 16.
It has been a long-term debate over the concomitant treatment of inflammatory acne vulgaris using intense pulsed light (IPL) and minocycline due to the photosensitivity of minocycline.
We aimed to evaluate the safety and efficiency of IPL combined with minocycline in treating acne vulgaris in a randomized trial.
A total of 40 patients were enrolled and randomly assigned into two groups which were either given minocycline (100 mg per day) for 8 weeks with IPL treatments three times at weeks 0, 4, and 8, or the same dosage of minocycline only. The evaluations for inflammatory lesion count, Investigator Global Assessment of Acne (IGA), erythema, and purpura indexes were taken before treatment and at weeks 4, 8, and 16.
There were significant improvements in inflammatory lesion count, IGA scores, and purpura index in both groups as compared with the baseline at week 16 (p < 0.02). The concomitant therapy, but not minocycline only, significantly improved the erythema index (p = 0.40) at the 16 week as compared with the baseline. The group with combined treatment showed significantly continuous improvements in inflammatory lesion counts (p < 0.04) and IGA scores (p ≤ 0.02) at weeks 4, 8, and 16 as compared with the group given minocycline only. No severe adverse effects were observed during the trial.
IPL in combination with minocycline shows a better clinical efficacy for the treatment of inflammatory acne vulgaris than minocycline alone, and it is safe.
由于米诺环素的光敏性,长期以来一直存在关于联合使用强脉冲光(IPL)和米诺环素治疗寻常痤疮的争议。
我们旨在通过随机试验评估 IPL 联合米诺环素治疗寻常痤疮的安全性和疗效。
共纳入 40 例患者,并随机分为两组,一组给予米诺环素(每天 100mg)治疗 8 周,同时在第 0、4 和 8 周进行 IPL 治疗三次,另一组仅给予相同剂量的米诺环素。在治疗前、第 4、8 和 16 周,评估炎症性病变计数、研究者全球评估痤疮(IGA)、红斑和瘀斑指数。
与基线相比,两组在第 16 周时炎症性病变计数、IGA 评分和瘀斑指数均有显著改善(p<0.02)。与基线相比,联合治疗组(而非仅用米诺环素组)在第 16 周时显著改善了红斑指数(p=0.40)。与仅用米诺环素组相比,联合治疗组在第 4、8 和 16 周时炎症性病变计数(p<0.04)和 IGA 评分(p≤0.02)均有显著的持续改善。在试验期间未观察到严重不良反应。
与单独使用米诺环素相比,IPL 联合米诺环素治疗寻常痤疮的临床疗效更好,且安全。